AI assistant
Sending…
DAVITA INC. — Director's Dealing 2016
May 25, 2016
30643_dirs_2016-05-24_4bec4517-e2da-4c3c-9f40-46e5ac58e64a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-05-23
Reporting Person: HILGER JAMES K (Interim CFO and CAO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-23 | Common Stock | M | 12000 | $55.34 | Acquired | 29147 | Direct |
| 2016-05-23 | Common Stock | F | 8584 | $77.37 | Disposed | 20563 | Direct |
| 2016-05-23 | Common Stock | S | 3416 | $76.7884 | Disposed | 17147 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-23 | Stock Appreciation Rights | $55.34 | M | 12000 | Disposed | 2017-12-18 | Common Stock (12000) | Direct |
Footnotes
F1: Represents the weighted average sale price of $76.7884. The range of prices for the sale of these shares was $76.75-$77.00, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: The Stock Appreciation Rights were granted on 12/18/2012. 50% vested on 4/1/2015 and the remaining 50% vested on 4/1/2016.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25